Cover Image
市場調查報告書

脊髓電刺激設備:開發平台分析

Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 345363
出版日期 內容資訊 英文 95 Pages
訂單完成後即時交付
價格
Back to Top
脊髓電刺激設備:開發平台分析 Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年11月01日 內容資訊: 英文 95 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的脊髓電刺激設備開發中產品資訊相關分析,提供您臨床實驗與產品開發的進展,彙整各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品的詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 脊髓電刺激設備概要

第3章 開發中的產品

  • 脊髓電刺激設備 - 各開發階段的開發中產品
  • 脊髓電刺激設備 -國家 (地區) 別的開發中產品
  • 脊髓電刺激設備 - 法規別的開發中產品
  • 脊髓電刺激設備 - 各認證時期 (估計) 的開發中產品
  • 脊髓電刺激設備 - 現在進行中的臨床實驗

第4章 脊髓電刺激設備 - 正在開發的開發中產品:各企業

  • 脊髓電刺激設備企業 - 各開發階段的開發中產品
  • 脊髓電刺激設備 - 各開發階段的開發中產品

第5章 脊髓電刺激設備企業與產品概要

  • Boston Scientific Corporation
  • Direct Spinal Therapeutics, Inc.
  • Duke University
  • Imperial College London
  • Meagan Medical Inc.
  • Medtrode Inc.
  • Medtronic plc
  • MicroTransponder Inc.
  • NeuroRecovery Technologies Inc.
  • Nuvectra Corporation
  • Saluda Medical Pty Ltd
  • St. Jude Medical, Inc.
  • Stimwave Technologies, Inc.

第6章 脊髓電刺激設備 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0243EPD

GlobalData's Medical Devices sector report, "Spinal Cord Stimulators - Medical Devices Pipeline Assessment, 2016" provides an overview of Spinal Cord Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Spinal Cord Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Spinal Cord Stimulators under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Spinal Cord Stimulators and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Spinal Cord Stimulators under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Spinal Cord Stimulators Overview

3. Products under Development

  • 3.1. Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • 3.2. Spinal Cord Stimulators - Pipeline Products by Territory
  • 3.3. Spinal Cord Stimulators - Pipeline Products by Regulatory Path
  • 3.4. Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
  • 3.5. Spinal Cord Stimulators - Ongoing Clinical Trials

4. Spinal Cord Stimulators - Pipeline Products under Development by Companies

  • 4.1. Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development
  • 4.2. Spinal Cord Stimulators - Pipeline Products by Stage of Development

5. Spinal Cord Stimulators Companies and Product Overview

  • 5.1. Direct Spinal Therapeutics, Inc. Company Overview
    • 5.1.1. Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Duke University Company Overview
    • 5.2.1. Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. G-Therapeutics SA Company Overview
    • 5.3.1. G-Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Imperial College London Company Overview
    • 5.4.1. Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Meagan Medical Inc. Company Overview
    • 5.5.1. Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Medtrode Inc. Company Overview
    • 5.6.1. Medtrode Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Medtronic plc Company Overview
    • 5.7.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. MicroTransponder Inc. Company Overview
    • 5.8.1. MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. NeuroRecovery Technologies Inc. Company Overview
    • 5.9.1. NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. PathMaker Neurosystems Inc Company Overview
    • 5.10.1. PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Saluda Medical Pty Ltd Company Overview
    • 5.11.1. Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. St. Jude Medical, Inc. Company Overview
    • 5.12.1. St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. University of Illinois at Chicago Company Overview
    • 5.13.1. University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview

6. Spinal Cord Stimulators- Recent Developments

  • 6.1. Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
  • 6.2. Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
  • 6.3. Oct 04, 2016: St. Jude Medical Announces FDA Approval of BurstDR Stimulation, a New Superior Spinal Cord Stimulation Option for Patients Suffering from Chronic Pain
  • 6.4. Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services
  • 6.5. Sep 13, 2016: PathMaker Neurosystems Announces the Addition of Institute Professor Emilio Bizzi of MIT to its Scientific Advisory Board
  • 6.6. Sep 06, 2016: Publication of Two-Year SENZA-RCT Results in Neurosurgery Demonstrates Sustained Superiority of HF10 Therapy over Traditional Spinal Cord Stimulation for Chronic Pain
  • 6.7. Aug 29, 2016: Stimwave's Drug-Free Wireless Pain Relief Neurostimulator Changing the Lives of People Suffering From Chronic Pain
  • 6.8. Aug 25, 2016: Medtronic Reports First Quarter Financial Results
  • 6.9. Aug 23, 2016: Novel Technology for Veterans with Spinal Cord Injury or ALS to be presented at this year's Paralyzed Veterans of America Summit in Orlando: NeuRx Diaphragm Pacing System Shows Benefit In SCI and ALS Patients
  • 6.10. Aug 10, 2016: Nuvectra Reports Second Quarter 2016 Financial Results
  • 6.11. Aug 09, 2016: Synapse Biomedical Awarded GSA Schedule for NeuRx Diaphragm Pacing System product line; device will benefit veterans with spinal cord injury (SCI) and ALS
  • 6.12. Aug 08, 2016: Nuvectra Announces Formation Of Medical Advisory Board
  • 6.13. Aug 08, 2016: Nevro Reports Second Quarter 2016 Financial Results
  • 6.14. Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
  • 6.15. Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
  • 6.16. Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
  • 6.17. Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
  • 6.18. Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
  • 6.19. Jun 06, 2016: Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million
  • 6.20. Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day
  • 6.21. Jun 02, 2016: PathMaker Neurosystems Announces Key Patent Issuance by US Patent and Trademark Office for Fundamental Technology Covering MyoRegulator
  • 6.22. May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results
  • 6.23. May 25, 2016: Hazard alert: Medtronic RestoreSensor implantable neurostimulators
  • 6.24. May 24, 2016: InCube Labs Enters into Agreement with University of Pittsburgh
  • 6.25. May 19, 2016: Boston Scientific Receives U.S. FDA Approval for Precision Montage MRI Spinal Cord Stimulator System
  • 6.26. May 11, 2016: Nuvectra Reports First Quarter 2016 Financial Results
  • 6.27. May 09, 2016: Nevro Reports First Quarter 2016 Financial Results
  • 6.28. Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion
  • 6.29. Apr 27, 2016: Boston Scientific Announces Results For First Quarter 2016
  • 6.30. Apr 26, 2016: Long-Term Follow Up Study Reports An Overwhelming Majority Of Patients Pleased With Diaphragm Pacing
  • 6.31. Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results
  • 6.32. Apr 19, 2016: G-Therapeutics Raises USD29.4 Million in Series A Financing
  • 6.33. Apr 11, 2016: St. Jude Medical Announces US Launch and First Commercial Implants of DRG Stimulation Therapy
  • 6.34. Apr 05, 2016: PathMaker Neurosystems and Feinstein Institute Announce Initiation of First Clinical Trial of MyoRegulator to Treat Muscle Contraction
  • 6.35. Apr 05, 2016: St. Jude Medical Announces MHLW Approvals of the Proclaim Elite MRI, a Patient-Centric and Recharge-Free Chronic Pain Treatment Option and New SCS Trial System - The Industry's First SCS Systems to Incorporate Apple Digital Devices enabling Japanese
  • 6.36. Mar 14, 2016: Nuvectra Begins Trading on NASDAQ
  • 6.37. Mar 03, 2016: Medtronic the First to Offer Complete Portfolio of Full-Body MR Conditional Neurostimulation Systems for Chronic Pain
  • 6.38. Feb 25, 2016: Boston Scientific Announces Changes to Board of Directors
  • 6.39. Feb 17, 2016: St. Jude Medical Announces FDA Approval Of A New Treatment Therapy For Patients Suffering From Chronic Intractable Pain
  • 6.40. Feb 04, 2016: Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2015
  • 6.41. Feb 02, 2016: Mostyn Law wins court order barring Boston Scientific from destroying evidence
  • 6.42. Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results
  • 6.43. Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results
  • 6.44. Dec 11, 2015: LUMINA Data Demonstrate 70 Percent Greater Low Back Pain Relief with Boston Scientific Precision Spectra Spinal Cord Stimulator System
  • 6.45. Dec 11, 2015: Long Term Data Confirms the St. Jude Medical Axium System Delivers Sustained and Superior Pain Relief for Patients with Chronic Lower Limb Pain
  • 6.46. Dec 11, 2015: New Data Demonstrates Burst Stimulation from St. Jude Medical Provides Superior Pain Relief over Traditional Tonic Spinal Cord Stimulation for the Treatment of Chronic Pain
  • 6.47. Dec 10, 2015: Stimwave Receives CE Mark Approval for World's First Wireless Injectable, Eight-Electrode High Frequency Programmable Neuromodulation System
  • 6.48. Dec 10, 2015: CMS Approves Transitional Pass-Through Payment for Outpatient Use of Nevro's Senza Spinal Cord Stimulation System
  • 6.49. Dec 09, 2015: Stimwave Receives FDA Clearance and Launches Commercialization for World's Smallest Fully-Programmable, Eight-Electrode Wireless Pain Relief SCS System
  • 6.50. Nov 30, 2015: St. Jude Medical Introduces Proclaim Elite SCS System In Europe
  • 6.51. Nov 30, 2015: Greatbatch Receives FDA Approval of Algovita Spinal Cord Stimulation System
  • 6.52. Nov 20, 2015: Northwest Ambulatory Surgery Center Conducts First Commercial Implantation Of The Senza Spinal Cord Stimulator (SCS) In Portland, Oregon
  • 6.53. Nov 19, 2015: St. Jude Medical Gets FDA Approval For Proclaim Elite SCS System
  • 6.54. Oct 29, 2015: PathMaker Neurosystems Receives Expedited Access Pathway Designation from FDA for MyoRegulator
  • 6.55. Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • Table 2: Spinal Cord Stimulators - Pipeline Products by Territory
  • Table 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path
  • Table 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
  • Table 5: Spinal Cord Stimulators - Ongoing Clinical Trials
  • Table 6: Spinal Cord Stimulators Companies - Pipeline Products by Stage of Development
  • Table 7: Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • Table 8: Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Iowa-Patch System - Product Status
  • Table 10: Iowa-Patch System - Product Description
  • Table 11: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Spinal Cord Stimulator - Product Status
  • Table 13: Spinal Cord Stimulator - Product Description
  • Table 14: G-Therapeutics SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Implantable Neuro-stimulation System - Product Status
  • Table 16: Implantable Neuro-stimulation System - Product Description
  • Table 17: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Wireless Intraspinal Microstimulation System - Product Status
  • Table 19: Wireless Intraspinal Microstimulation System - Product Description
  • Table 20: Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: DISCSS IFC System - Product Status
  • Table 22: DISCSS IFC System - Product Description
  • Table 23: Medtrode Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Implantable Pulse Generator - Product Status
  • Table 25: Implantable Pulse Generator - Product Description
  • Table 26: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Intellis RC - Product Status
  • Table 28: Intellis RC - Product Description
  • Table 29: MRI Surgical Lead - Product Status
  • Table 30: MRI Surgical Lead - Product Description
  • Table 31: PNS Device - Chronic Back Pain - Product Status
  • Table 32: PNS Device - Chronic Back Pain - Product Description
  • Table 33: PrimeADVANCED - Heart Failure - Product Status
  • Table 34: PrimeADVANCED - Heart Failure - Product Description
  • Table 35: MicroTransponder Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: SAINT System - Chronic Pain - Product Status
  • Table 37: SAINT System - Chronic Pain - Product Description
  • Table 38: NeuroRecovery Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: External Spinal Cord Neuromodulation System - Product Status
  • Table 40: External Spinal Cord Neuromodulation System - Product Description
  • Table 41: Implantable Spinal Cord Stimulation Device - Product Status
  • Table 42: Implantable Spinal Cord Stimulation Device - Product Description
  • Table 43: PathMaker Neurosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: MyoRegulator PM-2200 - Product Status
  • Table 45: MyoRegulator PM-2200 - Product Description
  • Table 46: PathMaker Neurosystems Inc - Ongoing Clinical Trials Overview
  • Table 47: MyoRegulator PM-2200 - First Clinical Trial of MyoRegulator to Treat Muscle Contraction
  • Table 48: Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Evoke Spinal Cord Stimulation System - Product Status
  • Table 50: Evoke Spinal Cord Stimulation System - Product Description
  • Table 51: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 52: Next Generation Implantable SCS System - Primary Cell - Product Status
  • Table 53: Next Generation Implantable SCS System - Primary Cell - Product Description
  • Table 54: Next Generation Implantable SCS System - Rechargeable - Product Status
  • Table 55: Next Generation Implantable SCS System - Rechargeable - Product Description
  • Table 56: Proclaim DRG - Product Status
  • Table 57: Proclaim DRG - Product Description
  • Table 58: Proclaim Rechargeable Model - Product Status
  • Table 59: Proclaim Rechargeable Model - Product Description
  • Table 60: Proclaim Upgrade HC - Product Status
  • Table 61: Proclaim Upgrade HC - Product Description
  • Table 62: Proclaim Upgrade LC - Product Status
  • Table 63: Proclaim Upgrade LC - Product Description
  • Table 64: Prodigy SCS System - Product Status
  • Table 65: Prodigy SCS System - Product Description
  • Table 66: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 67: Prodigy SCS System - A Post-market Study Evaluating the Prodigy Neuromodulation System for the Management of Failed Back Surgery Syndrome or Chronic Intractable Pain of the Trunk and/or Limbs
  • Table 68: Prodigy SCS System - Success Using Neuromodulation with BURST (SUNBURST) Study
  • Table 69: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
  • Table 70: Paddle Electrodes - Spinal Cord Stimulation - Product Status
  • Table 71: Paddle Electrodes - Spinal Cord Stimulation - Product Description
  • Table 72: Glossary

List of Figures

  • Figure 1: Spinal Cord Stimulators - Pipeline Products by Stage of Development
  • Figure 2: Spinal Cord Stimulators - Pipeline Products by Territory
  • Figure 3: Spinal Cord Stimulators - Pipeline Products by Regulatory Path
  • Figure 4: Spinal Cord Stimulators - Pipeline Products by Estimated Approval Date
  • Figure 5: Spinal Cord Stimulators - Ongoing Clinical Trials
Back to Top